<!DOCTYPE html SYSTEM "about:legacy-compat"><html lang="en-US" data-colors-preset="contrast" data-primary-color="#307FFF"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="UTF-8">  <meta name="built-on" content="2024-01-01T13:06:23.5259508"><meta name="build-number" content="${buildNumber}">       <title>恒瑞医药：与美国Elevar Therapeutics公司达成协议，将注射用卡瑞利珠单抗项目有偿许可给Elevar | 2023-10-17</title><script id="virtual-toc-data" type="application/json">[]</script><script id="topic-shortcuts" type="application/json"></script><link href="https://resources.jetbrains.com/writerside/apidoc/6.6.6-b205/app.css" rel="stylesheet">   <link rel="apple-touch-icon" sizes="180x180" href="https://jetbrains.com/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="https://jetbrains.com/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="https://jetbrains.com/favicon-16x16.png"><link rel="manifest" href="https://jetbrains.com/site.webmanifest"><link rel="mask-icon" href="https://jetbrains.com/safari-pinned-tab.svg" color="#000000"><meta name="msapplication-TileColor" content="#000000"/><meta name="msapplication-TileImage" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-144x144.png"/><meta name="msapplication-square70x70logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-70x70.png"/><meta name="msapplication-square150x150logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-150x150.png"/><meta name="msapplication-wide310x150logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-310x150.png"/><meta name="msapplication-square310x310logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-310x310.png"/>  <meta name="image" content=""><!-- Open Graph --><meta property="og:title" content="恒瑞医药：与美国Elevar Therapeutics公司达成协议，将注射用卡瑞利珠单抗项目有偿许可给Elevar | 2023-10-17"/><meta property="og:description" content=""/><meta property="og:image" content=""/><meta property="og:site_name" content="2023-10-17 Help"/><meta property="og:type" content="website"/><meta property="og:locale" content="en_US"/><meta property="og:url" content="4663.html"/><!-- End Open Graph --><!-- Twitter Card --><meta name="twitter:card" content="summary_large_image"><meta name="twitter:site" content=""><meta name="twitter:title" content="恒瑞医药：与美国Elevar Therapeutics公司达成协议，将注射用卡瑞利珠单抗项目有偿许可给Elevar | 2023-10-17"><meta name="twitter:description" content=""><meta name="twitter:creator" content=""><meta name="twitter:image:src" content=""><!-- End Twitter Card --><!-- Schema.org WebPage --><script type="application/ld+json"> { "@context": "http://schema.org", "@type": "WebPage", "@id": "4663.html#webpage", "url": "4663.html", "name": "恒瑞医药：与美国Elevar Therapeutics公司达成协议，将注射用卡瑞利珠单抗项目有偿许可给Elevar | 2023-10-17", "description": "", "image": "", "inLanguage":"en-US" }</script><!-- End Schema.org --><!-- Schema.org WebSite --><script type="application/ld+json"> { "@type": "WebSite", "@id": "/#website", "url": "/", "name": "2023-10-17 Help" }</script><!-- End Schema.org --></head>      <body data-id="4663" data-main-title="恒瑞医药：与美国Elevar Therapeutics公司达成协议，将注射用卡瑞利珠单抗项目有偿许可给Elevar" data-article-props="{&quot;seeAlsoStyle&quot;:&quot;links&quot;}"  data-template="article"  data-breadcrumbs=""  >   <div class="wrapper"><main class="panel _main"><header class="panel__header"><div class="container"><h3>2023-10-17  Help</h3><div class="panel-trigger"></div></div></header><section class="panel__content"><div class="container"><article class="article" data-shortcut-switcher="inactive"><h1 data-toc="4663"   id="4663.md">恒瑞医药：与美国Elevar Therapeutics公司达成协议，将注射用卡瑞利珠单抗项目有偿许可给Elevar</h1>  <p id="b87e7196_31"><span class="control" id="b87e7196_32">界面快报</span></p><p id="b87e7196_33"><span class="control" id="b87e7196_34">2023-10-17 04:41</span></p><p id="b87e7196_35"><span class="control" id="b87e7196_36">https://www.jiemian.com/article/10238630.html</span></p><p id="b87e7196_37">恒瑞医药10月17日公告，公司与美国Elevar Therapeutics公司达成协议，将具有自主知识产权的1类新药注射用卡瑞利珠单抗项目有偿许可给Elevar，Elevar将获得在除大中华区和韩国以外的全球范围内开发和商业化卡瑞利珠单抗联用治疗肝细胞癌的独家权利。</p><p id="b87e7196_38">据协议，根据卡瑞利珠单抗在美国、日本和约定的欧洲国家分别首次获批上市及未来每年净销售额实际情况，Elevar将在达到一定累计净销售额后向恒瑞支付累计6亿美元的销售里程碑款，并在超过一定累计净销售额后额外付款。Elevar将向恒瑞支付达到实际年净销售额20.5%的销售提成。</p><div class="last-modified"> Last modified: 01 一月 2024</div><div data-feedback-placeholder="true"></div><div class="navigation-links _bottom">  <a class="navigation-links__prev" href="4664.html">淘宝问问累计体验人次已超500万，非购物类需求占比达25%</a>   <a class="navigation-links__next" href="4662.html">石四药集团：利奈唑胺氯化钠注射液药品取得国药监局生产注册批件</a>  </div></article><div id="disqus_thread"></div></div></section></main></div>  <script src="https://resources.jetbrains.com/writerside/apidoc/6.6.6-b205/app.js"></script></body></html>